Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy, safety and tolerability of HZT-501, including users of low-dose aspirin (LDA), a single-tablet combination of ibuprofen-famotidine: results of two phase 3 trials. Weinblatt, M., Genovese, M. C., Kivitz, A., Bello, A. E., Grahn, A., Sherman, J. W., Schiff, M. H., Magelli, M. WILEY-BLACKWELL. 2012: E203
View details for Web of Science ID 000309452700090